Business Context and Reporting Period
Company: Glucotrack, Inc. (GCTK)
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2026
Event: Special Meeting of Stockholders held on March 12, 2026, to vote on proposals related to Nasdaq listing compliance and auditor ratification.
Key Financial Metrics
This filing is a current report regarding corporate governance and voting results. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
The Special Meeting addressed three primary proposals. As of the record date (January 28, 2026), there were 1,011,279 shares outstanding. Approximately 44.1% of eligible votes were represented at the meeting.
- Nasdaq Stock Issuance (ELOC) Proposal: Approved. This authorizes the full issuance of shares to Sixth Borough Capital Fund, LP, pursuant to a September 11, 2025 purchase agreement, which may exceed 20% of outstanding stock.
- Votes For: 126,610
- Votes Against: 18,261
- Abstentions: 7,846
- Nasdaq Stock Issuance (Warrants) Proposal: Approved. This authorizes the issuance of shares upon exercise of 2,067,182 warrants issued to an investor in a December 31, 2025 private placement.
- Votes For: 26,134 (excluding 100,591 "Excluded Shares" issued prior to the record date)
- Votes Against: 18,151
- Abstentions: 7,841
- Auditor Ratification Proposal: Approved. Ratified the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ended December 31, 2025.
- Votes For: 431,871
- Votes Against: 4,108
- Abstentions: 10,369
- Adjournment Proposal: Not presented, as all other proposals received sufficient favorable votes.
Guidance, Outlook, and Risks
The filing does not contain management guidance, future outlook, or specific risk factors beyond the context of complying with Nasdaq Listing Rule 5635(d) regarding significant stock issuances. The successful approval of the stock issuance proposals indicates the Company is proceeding with capital structures established in late 2025.
Investor Verification Checklist
- Verify the terms of the Purchase Agreement dated September 11, 2025, with Sixth Borough Capital Fund, LP, to understand the dilution impact of the ELOC issuance.
- Review the definitive proxy statement filed on February 9, 2026, for detailed descriptions of the Private Placement closed on December 31, 2025, and the associated warrant terms.
- Confirm the total number of shares outstanding post-issuance to assess the current ownership structure.
- Check subsequent filings for the actual issuance of shares related to the approved ELOC and warrant exercises.